GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $394,000 | -1.3% | 9,045 | 0.0% | 0.06% | -3.5% |
Q4 2021 | $399,000 | +17.4% | 9,045 | +1.5% | 0.06% | +7.5% |
Q3 2021 | $340,000 | -9.3% | 8,910 | -5.4% | 0.05% | -10.2% |
Q2 2021 | $375,000 | +5.6% | 9,415 | -5.4% | 0.06% | +1.7% |
Q1 2021 | $355,000 | -12.6% | 9,955 | -9.9% | 0.06% | -20.5% |
Q4 2020 | $406,000 | -4.2% | 11,045 | -2.0% | 0.07% | -8.8% |
Q3 2020 | $424,000 | -11.3% | 11,267 | -3.8% | 0.08% | -17.5% |
Q2 2020 | $478,000 | -5.2% | 11,707 | -12.0% | 0.10% | -44.3% |
Q1 2020 | $504,000 | -26.6% | 13,298 | -9.0% | 0.17% | -4.9% |
Q4 2019 | $687,000 | +11.5% | 14,613 | +1.2% | 0.18% | +2.8% |
Q3 2019 | $616,000 | +3.5% | 14,443 | -2.8% | 0.18% | +3.5% |
Q2 2019 | $595,000 | -3.1% | 14,863 | +1.2% | 0.17% | -7.0% |
Q1 2019 | $614,000 | +1.8% | 14,683 | -7.0% | 0.18% | -11.1% |
Q4 2018 | $603,000 | -2.7% | 15,793 | +2.3% | 0.21% | +14.9% |
Q3 2018 | $620,000 | +3.5% | 15,436 | +3.8% | 0.18% | -2.7% |
Q2 2018 | $599,000 | – | 14,866 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |